Tirzepatide Linked to Reduced Cardiovascular Risk Post-Intervention Tirzepatide is associated with reduced cardiovascular risks and improved outcomes in patients undergoing PCI and TAVR, according to new research. 02 May 2026 #Tirzepatide#CardiovascularHealth#GLP1RA#HeartResearch#MedicalBreakthrough
